$Oprozomib (OPZ) and Dexamethasone (DEX) in Patients (Pts) With Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Results From a Phase 1b/2, Multicenter, Open-Label Study$
QR Code

Oprozomib (OPZ) and Dexamethasone (DEX) in Patients (Pts) With Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Results From a Phase 1b/2, Multicenter, Open-Label Study

Saved in:

Bibliographic Details
Published in:	Clinical lymphoma, myeloma and leukemia Vol. 15; p. e273
Main Authors:	Prada, C.P, Shain, K.H, Voorhees, P, Gabrail, N, Abidi, M, Zonder, J, Boccia, R, Richardson, P.G, Neuman, L, Wong, H, Dixon, S, Hari, P
Format:	Journal Article
Language:	English
Published:	Elsevier Inc 01-09-2015
Subjects:	Hematology, Oncology and Palliative Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	2152-2650 2152-2669
DOI:	10.1016/j.clml.2015.07.569